-
1
-
-
0141617402
-
Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues
-
DOI 10.1002/sim.1557
-
Sankoh A, D'Agostino R, Huque M. Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues. Stat Med 2003;22:3133-50 (Pubitemid 37220623)
-
(2003)
Statistics in Medicine
, vol.22
, Issue.20
, pp. 3133-3150
-
-
Sankoh, A.J.1
D'Agostino Sr., R.B.2
Huque, M.F.3
-
2
-
-
77956112139
-
Definition, reporting, and interpretation of composite outcomes in clinical trials: Systematic review
-
Cordoba G, Schwartz L, Woloshin S, Bae H, Gøtzsche PC. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 2010;341:c3920
-
(2010)
BMJ
, vol.341
-
-
Cordoba, G.1
Schwartz, L.2
Woloshin, S.3
Bae, H.4
Gøtzsche, P.C.5
-
3
-
-
0037872688
-
Composite Outcomes in Randomized Trials: Greater Precision but with Greater Uncertainty?
-
DOI 10.1001/jama.289.19.2554
-
Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA 2003;289:2554-9 (Pubitemid 37430157)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2554-2559
-
-
Freemantle, N.1
Calvert, M.2
Wood, J.3
Eastaugh, J.4
Griffin, C.5
-
4
-
-
26844517347
-
Key issues in end point selection for heart failure trials: Composite end points
-
DOI 10.1016/j.cardfail.2005.08.350, PII S1071916405011802
-
Neaton J, Gray G, Zuckerman B, Konstam M. Key issues in end point selection for heart failure trials: composite end points. J Cardiac Fail 2005;11:567-75 (Pubitemid 41463726)
-
(2005)
Journal of Cardiac Failure
, vol.11
, Issue.8
, pp. 567-575
-
-
Neaton, J.D.1
Gray, G.2
Zuckerman, B.D.3
Konstam, M.A.4
-
5
-
-
33645227163
-
Some issues with composite endpoints in clinical trials
-
DOI 10.1111/j.1472-8206.2005.00370.x
-
Chi G. Some issues with composite endpoints in clinical trials. Fundam Clin Pharmacol 2005;19:609-19 (Pubitemid 43821995)
-
(2005)
Fundamental and Clinical Pharmacology
, vol.19
, Issue.6
, pp. 609-619
-
-
Chi, G.Y.H.1
-
6
-
-
74549205348
-
Composite end points in randomized trials: There is no free lunch
-
Tomlinson G, Detsky A. Composite end points in randomized trials: there is no free lunch. JAMA 2010;303:267-8
-
(2010)
JAMA
, vol.303
, pp. 267-268
-
-
Tomlinson, G.1
Detsky, A.2
-
7
-
-
0027763637
-
Global tests for multiple binary outcomes
-
Lefkopoulou M, Ryan L. Global tests for multiple binary outcomes. Biometrics 1993;49:975-88 (Pubitemid 24045276)
-
(1993)
Biometrics
, vol.49
, Issue.4
, pp. 975-988
-
-
Lefkopoulou, M.1
Ryan, L.2
-
8
-
-
84890495334
-
Efficiency and power of tests for multiple binary outcomes
-
Legler JM, Lefkopoulou M, Ryan LM. Efficiency and power of tests for multiple binary outcomes. J Am Stat Assoc 1995;90:680-93
-
(1995)
J Am Stat Assoc
, vol.90
, pp. 680-693
-
-
Legler, J.M.1
Lefkopoulou, M.2
Ryan, L.M.3
-
9
-
-
78649614785
-
Factors affecting power of tests for multiple binary outcomes
-
Mascha EJ, Imrey PB. Factors affecting power of tests for multiple binary outcomes. Stat Med 2010;29:2890-904
-
(2010)
Stat Med
, vol.29
, pp. 2890-2904
-
-
Mascha, E.J.1
Imrey, P.B.2
-
10
-
-
0032531745
-
Regression models for multiple outcomes in large epidemiologic studies
-
DOI 10.1002/(SICI)1097-0258(19981015)17:19<2179::AID-SIM921>3.0. CO;2-L
-
Bull SB. Regression models for multiple outcomes in large epidemiologic studies. Stat Med 1998;17:2179-97 (Pubitemid 28466817)
-
(1998)
Statistics in Medicine
, vol.17
, Issue.19
, pp. 2179-2197
-
-
Bull, S.B.1
-
11
-
-
0028783948
-
Tissue plasminogen activator for acute ischemic stroke
-
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
-
The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-8
-
(1995)
N Engl J Med
, vol.333
, pp. 1581-1588
-
-
-
12
-
-
52949087530
-
Determining the most appropriate components for a composite clinical trial outcome
-
Bethel MA, Holman R, Haffner SM, Califf RM, Huntsman-Labed A, Hua TA, McMurray J. Determining the most appropriate components for a composite clinical trial outcome. Am Heart J 2008;156:633-40
-
(2008)
Am Heart J
, vol.156
, pp. 633-640
-
-
Bethel, M.A.1
Holman, R.2
Haffner, S.M.3
Califf, R.M.4
Huntsman-Labed, A.5
Hua, T.A.6
McMurray, J.7
-
13
-
-
0030723636
-
Clinical trials with multiple outcomes: A statistical perspective on their design, analysis, and interpretation
-
DOI 10.1016/S0197-2456(97)00008-1, PII S0197245697000081
-
Pocock S. Clinical trials with multiple outcomes: a statistical perspective on their design, analysis and interpretation. Control Clin Trials 1997;18:530-45 (Pubitemid 27520841)
-
(1997)
Controlled Clinical Trials
, vol.18
, Issue.6
, pp. 530-545
-
-
Pocock, S.J.1
-
14
-
-
65349168834
-
Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials
-
Ferreira-Gonzalez I, Permanyer-Miralda G, Busse JW, De-vereaux PJ, Guyatt GH, Alonso-Coello P, Montori VM. Composite outcomes can distort the nature and magnitude of treatment benefits in clinical trials. Ann Intern Med 2009;150:566-7
-
(2009)
Ann Intern Med
, vol.150
, pp. 566-567
-
-
Ferreira-Gonzalez, I.1
Permanyer-Miralda, G.2
Busse, J.W.3
De-Vereaux, P.J.4
Guyatt, G.H.5
Alonso-Coello, P.6
Montori, V.M.7
-
15
-
-
77957918954
-
Pros and cons of composite endpoints in anesthesia trials
-
Myles PS, Devereaux PJ. Pros and cons of composite endpoints in anesthesia trials. Anesthesiology 2010;113:776-8
-
(2010)
Anesthesiology
, vol.113
, pp. 776-778
-
-
Myles, P.S.1
Devereaux, P.J.2
-
16
-
-
78649571139
-
Validity of composite end points in clinical trials
-
Montori V, Permanyer G, Ferreira I, Busse J, Pacheco-Huergo V, Bryant D, Alonso J, Akl E, Domingo-Salvany A, Mills E, Wu P, Schünemann HJ, Jaeschke R, Guyatt G. Validity of composite end points in clinical trials. BMJ 2009;330:3
-
(2009)
BMJ
, vol.330
, pp. 3
-
-
Montori, V.1
Permanyer, G.2
Ferreira, I.3
Busse, J.4
Pacheco-Huergo, V.5
Bryant, D.6
Alonso, J.7
Akl, E.8
Domingo-Salvany, A.9
Mills, E.10
Wu, P.11
Schünemann, H.J.12
Jaeschke, R.13
Guyatt, G.14
-
17
-
-
34250017219
-
Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns
-
DOI 10.1016/j.jclinepi.2006.10.020, PII S0895435606004938
-
Ferreira-Gonzalez I, Permanyer-Miralda G, Busse J, Bryant D, Montori V, Alonso-Coello P, Walter S, Guyatt G. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J Clin Epidemiol 2007;60:651-7 (Pubitemid 46901008)
-
(2007)
Journal of Clinical Epidemiology
, vol.60
, Issue.7
, pp. 651-657
-
-
Ferreira-Gonzalez, I.1
Permanyer-Miralda, G.2
Busse, J.W.3
Bryant, D.M.4
Montori, V.M.5
Alonso-Coello, P.6
Walter, S.D.7
Guyatt, G.H.8
-
18
-
-
79953185714
-
Smoking and perioperative outcomes
-
Turan A, Mascha EJ, Roberman D, Turner P, You J, Kurz A, Sessler DI, Saager L. Smoking and perioperative outcomes. Anesthesiology 2010;114:837-46
-
(2010)
Anesthesiology
, vol.114
, pp. 837-846
-
-
Turan, A.1
Mascha, E.J.2
Roberman, D.3
Turner, P.4
You, J.5
Kurz, A.6
Sessler, D.I.7
Saager, L.8
-
19
-
-
27744591874
-
The NSQIP: A new frontier in surgery
-
DOI 10.1016/j.surg.2005.08.016, PII S0039606005005106
-
Khuri SF. The NSQIP: a new frontier in surgery. Surgery 2005;138:837-43 (Pubitemid 41608477)
-
(2005)
Surgery
, vol.138
, Issue.5
, pp. 837-843
-
-
Khuri, S.F.1
-
21
-
-
77951622706
-
The central role of the propensity score in observational studies for causal effects
-
Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55
-
(1983)
Biometrika
, vol.70
, pp. 41-55
-
-
Rosenbaum, P.1
Rubin, D.2
-
22
-
-
44349168172
-
Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial
-
Poise Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008;371:1839-47
-
(2008)
Lancet
, vol.371
, pp. 1839-1847
-
-
-
24
-
-
77954970861
-
Testing for heterogeneity among the components of a binary composite outcome in a clinical trial
-
Pogue J, Thabane L, Devereaux PJ, Yusuf S. Testing for heterogeneity among the components of a binary composite outcome in a clinical trial. BMC Med Res Methodol 2010;10:49
-
(2010)
BMC Med Res Methodol
, vol.10
, pp. 49
-
-
Pogue, J.1
Thabane, L.2
Devereaux, P.J.3
Yusuf, S.4
-
25
-
-
0002294347
-
A simple sequentially rejective multiple test procedure
-
Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979;6:65-70
-
(1979)
Scand J Stat
, vol.6
, pp. 65-70
-
-
Holm, S.1
-
27
-
-
77649173768
-
Longitudinal data analysis using generalized linear models
-
Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22
-
(1986)
Biometrika
, vol.73
, pp. 13-22
-
-
Liang, K.Y.1
Zeger, S.L.2
-
28
-
-
0022673130
-
Longitudinal data analysis for discrete and continuous outcomes
-
Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30
-
(1986)
Biometrics
, vol.42
, pp. 121-130
-
-
Zeger, S.L.1
Liang, K.Y.2
-
29
-
-
0029807710
-
Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t- PA Stroke Trial
-
Tilley B, Marler J, Geller N, Lu M, Legler J, Brott T, Lyden P, Grotta J, for the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial Study Group. Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. Stroke 1996;27:2136-42 (Pubitemid 26372593)
-
(1996)
Stroke
, vol.27
, Issue.11
, pp. 2136-2142
-
-
Tilley, B.C.1
Marler, J.2
Geller, N.L.3
Lu, M.4
Legler, J.5
Brott, T.6
Lyden, P.7
Grotta, J.8
-
31
-
-
0026551688
-
The use of subjective rankings in clinical trials with an application to cardiovascular disease
-
Follmann D, Wittes J, Cutler JA. The use of subjective rankings in clinical trials with an application to cardiovascular disease. Stat Med 1992;11:427-37
-
(1992)
Stat Med
, vol.11
, pp. 427-437
-
-
Follmann, D.1
Wittes, J.2
Cutler, J.A.3
-
32
-
-
77956018782
-
Analyzing composite outcomes in cardiovascular studies: Traditional Cox proportional hazards versus quality-of-life-adjusted survival approaches
-
Eurich DT, Majumdar SR, McAlister F, Tsuyuki R, Yasui Y, Johnson J. Analyzing composite outcomes in cardiovascular studies: traditional Cox proportional hazards versus quality-of-life-adjusted survival approaches. Open Med 2010;4:40-8
-
(2010)
Open Med
, vol.4
, pp. 40-48
-
-
Eurich, D.T.1
Majumdar, S.R.2
McAlister, F.3
Tsuyuki, R.4
Yasui, Y.5
Johnson, J.6
|